PMC:7396557 / 29725-29886 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T159","span":{"begin":41,"end":45},"obj":"UBERON:0000165"},{"id":"T160","span":{"begin":46,"end":67},"obj":"CHEBI:7799;CHEBI:7799"},{"id":"T161","span":{"begin":139,"end":160},"obj":"CHEBI:7799;CHEBI:7799"},{"id":"T44628","span":{"begin":41,"end":45},"obj":"UBERON:0000165"},{"id":"T50011","span":{"begin":46,"end":67},"obj":"CHEBI:7799;CHEBI:7799"},{"id":"T5582","span":{"begin":139,"end":160},"obj":"CHEBI:7799;CHEBI:7799"}],"text":"Patients in the control group were given oral oseltamivir phosphate, while patients in the observation group received HXZQC in addition to oseltamivir phosphate."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T229","span":{"begin":24,"end":29},"obj":"Chemical"},{"id":"T230","span":{"begin":46,"end":67},"obj":"Chemical"},{"id":"T231","span":{"begin":46,"end":57},"obj":"Chemical"},{"id":"T232","span":{"begin":58,"end":67},"obj":"Chemical"},{"id":"T236","span":{"begin":103,"end":108},"obj":"Chemical"},{"id":"T237","span":{"begin":139,"end":160},"obj":"Chemical"},{"id":"T238","span":{"begin":139,"end":150},"obj":"Chemical"},{"id":"T239","span":{"begin":151,"end":160},"obj":"Chemical"}],"attributes":[{"id":"A229","pred":"chebi_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A230","pred":"chebi_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/CHEBI_7799"},{"id":"A231","pred":"chebi_id","subj":"T231","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A232","pred":"chebi_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/CHEBI_18367"},{"id":"A233","pred":"chebi_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/CHEBI_26020"},{"id":"A234","pred":"chebi_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/CHEBI_35780"},{"id":"A235","pred":"chebi_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/CHEBI_43474"},{"id":"A236","pred":"chebi_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A237","pred":"chebi_id","subj":"T237","obj":"http://purl.obolibrary.org/obo/CHEBI_7799"},{"id":"A238","pred":"chebi_id","subj":"T238","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A239","pred":"chebi_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/CHEBI_18367"},{"id":"A240","pred":"chebi_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/CHEBI_26020"},{"id":"A241","pred":"chebi_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/CHEBI_35780"},{"id":"A242","pred":"chebi_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/CHEBI_43474"}],"text":"Patients in the control group were given oral oseltamivir phosphate, while patients in the observation group received HXZQC in addition to oseltamivir phosphate."}

{"project":"LitCovid-sentences","denotations":[{"id":"T230","span":{"begin":0,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients in the control group were given oral oseltamivir phosphate, while patients in the observation group received HXZQC in addition to oseltamivir phosphate."}

{"project":"LitCovid-PubTator","denotations":[{"id":"867","span":{"begin":0,"end":8},"obj":"Species"},{"id":"868","span":{"begin":75,"end":83},"obj":"Species"},{"id":"878","span":{"begin":46,"end":67},"obj":"Chemical"},{"id":"879","span":{"begin":118,"end":123},"obj":"Chemical"},{"id":"880","span":{"begin":139,"end":160},"obj":"Chemical"}],"attributes":[{"id":"A867","pred":"tao:has_database_id","subj":"867","obj":"Tax:9606"},{"id":"A868","pred":"tao:has_database_id","subj":"868","obj":"Tax:9606"},{"id":"A878","pred":"tao:has_database_id","subj":"878","obj":"MESH:D053139"},{"id":"A880","pred":"tao:has_database_id","subj":"880","obj":"MESH:D053139"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Patients in the control group were given oral oseltamivir phosphate, while patients in the observation group received HXZQC in addition to oseltamivir phosphate."}